I really don't see this going much higher. I would guess the trial has about a 90% to95% of passing with flying colors. But that 5% to 10% is going to keep a bit of a lid on the price. If results are good as we hope, I could see close to a double when the results are announced.
Let's face it, if the trials fall short, we could be a $1.00 stock. How high will someone risk that? I have bought more recently, but still have an average cost of a little over $4.00. Not sure yet if I let it ride and go for it all, or take some off the table. May hedge it with some puts.
As I mentioned earlier, I think the trials pass easily, but nothing is guaranteed and this is a one trick pony!
A. Higher, near the previous top 7.50 - 8 or perhaps slightly above it.
By Mid-August, B. about the same. I expect a sell-off before results are announced to bring it back down to around 7. That's a typical pattern... but not guaranteed, just speculation.
Earlier predictions on this board by many were
6 - 8 going into Mid-August,
8 - 10 on good results,
10 - 12 on partner announcement or FDA approval.